(c) 2024 PillSync.com

pravastatin sodium 10 MG Oral Tablet

1 INDICATIONS AND USAGE Pravastatin sodium tablets are indicated: 1. To reduce the risk of myocardial infarction, myocardial revascularization procedures, and cardiovascular mortality in adults with elevated low-density lipoprotein cholesterol (LDL-C) without clinically evident coronary heart disease (CHD). 2. To reduce the risk of coronary death, myocardial infarction, myocardial revascularization procedures, stroke or transient ischemic attack, and slow the progression of coronary atherosclerosis in adults with clinically evident CHD. 3. As an adjunct to diet to reduce LDL-C in adults with primary hyperlipidemia. 4. As an adjunct to diet to reduce LDL-C in pediatric patients ages 8 years and older with heterozygous familial hypercholesterolemia (HeFH). 5. As an adjunct to diet for the treatment of adults with: • Primary dysbetalipoproteinemia. • Hypertriglyceridemia. Pravastatin sodium tablets are an HMG-CoA reductase inhibitor (statin) indicated ( 1 ): • To reduce the risk of myocardial infarction, myocardial revascularization procedures, and cardiovascular mortality in adults with elevated low-density lipoprotein cholesterol (LDL-C) without clinically evident coronary heart disease (CHD). • To reduce the risk of coronary death, myocardial infarction, myocardial revascularization procedures, stroke or transient ischemic attack, and slow the progression of coronary atherosclerosis in adults with clinically evident CHD. • As an adjunct to diet to reduce LDL-C in adults with primary hyperlipidemia. • As an adjunct to diet to reduce LDL-C in pediatric patients ages 8 years and older with heterozygous familial hypercholesterolemia (HeFH). • As an adjunct to diet for the treatment of adults with: • Primary dysbetalipoproteinemia. • Hypertriglyceridemia.

Glenmark Pharmaceuticals Inc., USA


2 years ago ROUND YELLOW G5 10 pravastatin sodium 10 MG Oral Tablet

ROUND YELLOW G5 10

2 years ago ROUND YELLOW G5 10 pravastatin sodium 10 MG Oral Tablet

G5 10 ROUND YELLOW

16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied

PRAVASTATIN SODIUM Tablets, USP are supplied as: Strength How Supplied NDC Tablet Description 10 mg of

PRAVASTATIN SODIUM, USP bottles of 90 68462-195-90 yellow colored, circular shaped, flat faced tablets with “G5” debossed on one side and “10” debossed on the other side. Bottles contain a desiccant canister. bottles of 500 68462-195-05 20 mg of

PRAVASTATIN SODIUM, USP bottles of 90 68462-196-90 yellow, rounded-rectangular, biconvex tablets with “G5” debossed on one side and “20” debossed on the other side. Bottles contain a desiccant canister. bottles of 500 68462-196-05 40 mg of

PRAVASTATIN SODIUM, USP bottles of 90 68462-197-90 green, rounded-rectangular, biconvex tablets with “G5” debossed on one side and “40” debossed on the other side. Bottles contain a desiccant canister. bottles of 500 68462-197-05 80 mg of

PRAVASTATIN SODIUM, USP bottles of 90 68462-198-90 yellow, oval, biconvex tablets with “G5” debossed on one side and “80” debossed on the other side. Bottles contain a desiccant canister. bottles of 500 68462-198-05 Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [See USP Controlled Room Temperature]. Keep tightly closed (protect from moisture). Protect from light.


More pills like ROUND G5 10

Related Pills

pravastatin sodium 40 mg

Glenmark Pharmaceuticals Inc., USA

pravastatin sodium 20 mg

Glenmark Pharmaceuticals Inc., USA












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site